<DOC>
	<DOCNO>NCT02498418</DOCNO>
	<brief_summary>The primary objective demonstrate rifaximin 200-mg tablet ( test ) Xifaxan® 200 mg tablet ( reference ) clinically bioequivalent respect clinical cure rate administer 3 time day ( TID ) 3 day subject traveler ' diarrhea .</brief_summary>
	<brief_title>Study Comparing Rifaximin With Xifaxan 200mg Traveler 's Diarrhea</brief_title>
	<detailed_description>This randomize , placebo-controlled bioequivalent study clinical endpoint treatment traveler ' diarrhea . After three unformed stool record within 24 hour immediately precede randomization , subject randomize receive generic rifaximin 200 mg oral tablet , reference list drug ( RLD ) 200 mg oral tablet placebo three time daily 3 day ( i.e. , study Days 1 , 2 , 3 ) . The primary endpoint clinical cure test cure ( TOC ) visit study Day 5 .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>1 . Adult male nonpregnant female age ≥ 18 year nonindigenous traveler ( e.g. , visit students/faculty international tourist ) affect naturally acquire acute diarrhea . Diarrhea define passage least three unformed stool 24hour period . Stools classify form ( retains shape ) , soft ( assumes shape container ) , watery ( pour ) . When use classification , soft watery stool unformed abnormal . 2 . At least three unformed stool record within 24 hour immediately precede randomization . 3 . At least one follow sign symptom enteric infection : abdominal pain cramp nausea vomit fecal urgency excessive gas/flatulence tenesmus 4 . Women childbearing potential negative pregnancy test prior begin therapy agree use effective contraceptive method study . 1 . Pregnant , breast feeding , plan pregnancy . 2 . Immediately prior randomization , acute diarrhea &gt; 72 hour . 3 . Presence : fever ( ≥ 100 °F ≥ 37.8 °C ) , hematochezia ( blood stool ) , clinical finding suggest moderate severe dehydration . 4 . Active , uncontrolled , clinically significant disease disorder heart , lung , kidney , GI tract ( infectious diarrhea traveler ) , central nervous system . 5 . Administration follow : antimicrobial agent expect activity enteric bacterial pathogen within 7 day precede randomization two dos symptomatic antidiarrheal compound antimotility agent , absorbent agent , antisecretory agent within 8 hour precede randomization 6 . Use drug aspirin ibuprofen ( Advil ) , cause GI bleeding . Acetaminophen ( Tylenol ) paracetamol acceptable . 7 . If require study antimalarial prophylactic treatment , include doxycycline , permit prior study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>